Piramal Pharma Limited at its board meeting held on May 10, 2024, recommended a final dividend of INR 0.11 per Equity Share of INR 10 each for the financial year ended 31 March 2024, which will be paid /dispatched after the 4th Annual General Meeting, subject to the approval of shareholders of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
144.8 INR | -3.21% | -3.27% | +4.29% |
05-14 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
05-13 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.29% | 2.39B | |
+42.83% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+18.06% | 325B | |
+4.63% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.43% | 166B |
- Stock Market
- Equities
- PPLPHARMA Stock
- News Piramal Pharma Limited
- Piramal Pharma Limited Recommends Final Dividend for the Financial Year Ended 31 March 2024